| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
1 The Sidney Kimmel Comprehensive Cancer Center, 2 The Program in Human Genetics, and 3 Graduate Program in Cellular and Molecular Medicine, The Johns Hopkins University School of Medicine; and 4 The University of Maryland Greenebaum Cancer Center, The University of Maryland School of Medicine, Baltimore, Maryland
Requests for reprints: Kornel E. Schuebel or Stephen B. Baylin, Cancer Biology, The Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Room 530, 1650 Orleans Street, Baltimore, MD 21231. Phone: 410-955-8506; E-mail: kornels{at}jhmi.edu or sbaylin{at}jhmi.edu.
A major obstacle toward understanding how patterns of abnormal mammalian cytosine DNA methylation are established is the difficulty in quantitating the de novo methylation activities of DNA methyltransferases (DNMT) thought to catalyze these reactions. Here, we describe a novel method, using native human CpG island substrates from genes that frequently become hypermethylated in cancer, which generates robust activity for measuring de novo CpG methylation. We then survey colon cancer cells with genetically engineered deficiencies in different DNMTs and find that the major activity against these substrates in extracts of these cells is DNMT1, with minor contribution from DNMT 3b and none from DNMT3a, the only known bona fide de novo methyltransferases. The activity of DNMT1 against unmethylated CpG rich DNA was further tested by introducing CpG island substrates and DNMT1 into Drosophila melanogaster cells. The exogenous DNMT1 methylates the integrated mammalian CpG islands but not the Drosophila DNA. Additionally, in human cancer cells lacking DNMT1 and DNMT3b and having nearly absent genomic methylation, gene-specific de novo methylation can be initiated by reintroduction of DNMT1. Our studies provide a new assay for de novo activity of DNMTs and data suggesting a potential role for DNMT1 in the initiation of promoter CpG island hypermethylation in human cancer cells. (Cancer Res 2006; 66(2): 682-92)
This article has been cited by other articles:
|
|
 |
|
  L.-P. Wu, X. Wang, L. Li, Y. Zhao, S. Lu, Y. Yu, W. Zhou, X. Liu, J. Yang, Z. Zheng, et al. Histone Deacetylase Inhibitor Depsipeptide Activates Silenced Genes through Decreasing both CpG and H3K9 Methylation on the Promoter Mol. Cell. Biol., May 15, 2008; 28(10): 3219 - 3235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Dunican, A. Ruzov, J. A. Hackett, and R. R. Meehan xDnmt1 regulates transcriptional silencing in pre-MBT Xenopus embryos independently of its catalytic function Development, April 1, 2008; 135(7): 1295 - 1302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. V. Bagnyukova, V. P. Tryndyak, B. Montgomery, M. I. Churchwell, A. R. Karpf, S. R. James, L. Muskhelishvili, F. A. Beland, and I. P. Pogribny Genetic and epigenetic changes in rat preneoplastic liver tissue induced by 2-acetylaminofluorene Carcinogenesis, March 1, 2008; 29(3): 638 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Myant and I. Stancheva LSH Cooperates with DNA Methyltransferases To Repress Transcription Mol. Cell. Biol., January 1, 2008; 28(1): 215 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fini, M. Selgrad, V. Fogliano, G. Graziani, M. Romano, E. Hotchkiss, Y. A. Daoud, E. B. De Vol, C. R. Boland, and L. Ricciardiello Annurca Apple Polyphenols Have Potent Demethylating Activity and Can Reactivate Silenced Tumor Suppressor Genes in Colorectal Cancer Cells J. Nutr., December 1, 2007; 137(12): 2622 - 2628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Smallwood, P.-O. Esteve, S. Pradhan, and M. Carey Functional cooperation between HP1 and DNMT1 mediates gene silencing Genes & Dev., May 15, 2007; 21(10): 1169 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-O. Esteve, H. G. Chin, and S. Pradhan Molecular Mechanisms of Transactivation and Doxorubicin-mediated Repression of survivin Gene in Cancer Cells J. Biol. Chem., January 26, 2007; 282(4): 2615 - 2625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Morey, D. J. Smiraglia, S. R. James, J. Yu, M. T. Moser, B. A. Foster, and A. R. Karpf DNA Methylation Pathway Alterations in an Autochthonous Murine Model of Prostate Cancer Cancer Res., December 15, 2006; 66(24): 11659 - 11667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Oda, A. Yamagiwa, S. Yamamoto, T. Nakayama, A. Tsumura, H. Sasaki, K. Nakao, E. Li, and M. Okano DNA methylation regulates long-range gene silencing of an X-linked homeobox gene cluster in a lineage-specific manner Genes & Dev., December 15, 2006; 20(24): 3382 - 3394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Ting, K. M. McGarvey, and S. B. Baylin The cancer epigenome--components and functional correlates Genes & Dev., December 1, 2006; 20(23): 3215 - 3231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dokras, J. Coffin, L. Field, A. Frakes, H. Lee, A. Madan, T. Nelson, G.-Y. Ryu, J.-G. Yoon, and A. Madan Epigenetic regulation of maspin expression in the human placenta Mol. Hum. Reprod., October 1, 2006; 12(10): 611 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Kareta, Z. M. Botello, J. J. Ennis, C. Chou, and F. Chedin Reconstitution and Mechanism of the Stimulation of de Novo Methylation by Human DNMT3L J. Biol. Chem., September 8, 2006; 281(36): 25893 - 25902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Majumder, K. Ghoshal, J. Datta, D. S. Smith, S. Bai, and S. T. Jacob Role of DNA Methyltransferases in Regulation of Human Ribosomal RNA Gene Transcription J. Biol. Chem., August 4, 2006; 281(31): 22062 - 22072. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
